Cargando…

PANK1 associates with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a retrospective prognostic study based on the TCGA database

BACKGROUND: Identify key biomarkers to improve the clinical prognosis of patients with advanced and metastatic clear cell renal cell carcinoma (ccRCC) remains an important research topic. Recently, ccRCC has been regarded as a metabolic disease. Pantothenate kinase-1 (PANK1) has been shown to play a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bin, Liu, Bin, Luo, Qing, Sun, Ding, Li, Hao, Zhang, Jie, Jin, Xinye, Cheng, Xiaowei, Niu, Jingxue, Yuan, Qing, Chen, Yizhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372198/
https://www.ncbi.nlm.nih.gov/pubmed/35966310
http://dx.doi.org/10.21037/tcr-22-1488
_version_ 1784767327660670976
author Wang, Bin
Liu, Bin
Luo, Qing
Sun, Ding
Li, Hao
Zhang, Jie
Jin, Xinye
Cheng, Xiaowei
Niu, Jingxue
Yuan, Qing
Chen, Yizhi
author_facet Wang, Bin
Liu, Bin
Luo, Qing
Sun, Ding
Li, Hao
Zhang, Jie
Jin, Xinye
Cheng, Xiaowei
Niu, Jingxue
Yuan, Qing
Chen, Yizhi
author_sort Wang, Bin
collection PubMed
description BACKGROUND: Identify key biomarkers to improve the clinical prognosis of patients with advanced and metastatic clear cell renal cell carcinoma (ccRCC) remains an important research topic. Recently, ccRCC has been regarded as a metabolic disease. Pantothenate kinase-1 (PANK1) has been shown to play an important regulatory role in global metabolism and associates with the pathogenesis of hepatocellular carcinoma. Therefore, we aimed to investigate the role of PANK1 in the prognosis of ccRCC and in metabolism and immunity. METHODS: PANK1 messenger ribonucleic acid (RNA) expression patterns in ccRCC using The Cancer Genome Atlas (TCGA) database. The clinical prognostic significance of PANK1 in ccRCC and a Cox regression was performed to evaluate the clinical factors associated with prognosis with confounding factors adjusted. The signaling pathways related to PANK1 expression were identified by Gene Ontology (GO) investigation and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. The Tumor Immune Estimation Resource database was used to analyze the correlation between PANK1 and tumor-infiltrating immune cells. RESULTS: A total of 539 ccRCC patients and corresponding clinical samples and data from TCGA were included in this analysis. Significant differences were observed in PANK1 expression levels between tumor tissues and adjacent normal tissues in both TCGA-Kidney Renal Clear Cell Carcinoma cohort (4.40 vs. 2.94, P<0.001). PANK1 expression was found to be correlated with pathological stage, histological grade, age, sex, and clinical prognosis. Specifically, the low expression of PANK1 was found to be closely related to poor overall survival (OS), disease-specific survival (DSS), and the progression-free survival (PFS) in ccRCC patients. The receiver operating characteristic curve suggested that PANK1 could be a potential prognostic biomarker (area under the curve =0.880), and that the promoter methylation levels of PANK1 were correlated with clinical factors. Further, PANK1 expression was found to be associated with multiple immune cell types and correlated with the enrichment of these cells. Finally, we further investigated the role of PANK1 in tumor growth and mitochondrial metabolism using ccRCC cells. CONCLUSIONS: PANK1 correlates with ccRCC prognosis, tumor immune status and metabolism using the TCGA data. PANK1 might be a prognostic marker of clinical prognosis for ccRCC patients.
format Online
Article
Text
id pubmed-9372198
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-93721982022-08-13 PANK1 associates with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a retrospective prognostic study based on the TCGA database Wang, Bin Liu, Bin Luo, Qing Sun, Ding Li, Hao Zhang, Jie Jin, Xinye Cheng, Xiaowei Niu, Jingxue Yuan, Qing Chen, Yizhi Transl Cancer Res Original Article BACKGROUND: Identify key biomarkers to improve the clinical prognosis of patients with advanced and metastatic clear cell renal cell carcinoma (ccRCC) remains an important research topic. Recently, ccRCC has been regarded as a metabolic disease. Pantothenate kinase-1 (PANK1) has been shown to play an important regulatory role in global metabolism and associates with the pathogenesis of hepatocellular carcinoma. Therefore, we aimed to investigate the role of PANK1 in the prognosis of ccRCC and in metabolism and immunity. METHODS: PANK1 messenger ribonucleic acid (RNA) expression patterns in ccRCC using The Cancer Genome Atlas (TCGA) database. The clinical prognostic significance of PANK1 in ccRCC and a Cox regression was performed to evaluate the clinical factors associated with prognosis with confounding factors adjusted. The signaling pathways related to PANK1 expression were identified by Gene Ontology (GO) investigation and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. The Tumor Immune Estimation Resource database was used to analyze the correlation between PANK1 and tumor-infiltrating immune cells. RESULTS: A total of 539 ccRCC patients and corresponding clinical samples and data from TCGA were included in this analysis. Significant differences were observed in PANK1 expression levels between tumor tissues and adjacent normal tissues in both TCGA-Kidney Renal Clear Cell Carcinoma cohort (4.40 vs. 2.94, P<0.001). PANK1 expression was found to be correlated with pathological stage, histological grade, age, sex, and clinical prognosis. Specifically, the low expression of PANK1 was found to be closely related to poor overall survival (OS), disease-specific survival (DSS), and the progression-free survival (PFS) in ccRCC patients. The receiver operating characteristic curve suggested that PANK1 could be a potential prognostic biomarker (area under the curve =0.880), and that the promoter methylation levels of PANK1 were correlated with clinical factors. Further, PANK1 expression was found to be associated with multiple immune cell types and correlated with the enrichment of these cells. Finally, we further investigated the role of PANK1 in tumor growth and mitochondrial metabolism using ccRCC cells. CONCLUSIONS: PANK1 correlates with ccRCC prognosis, tumor immune status and metabolism using the TCGA data. PANK1 might be a prognostic marker of clinical prognosis for ccRCC patients. AME Publishing Company 2022-07 /pmc/articles/PMC9372198/ /pubmed/35966310 http://dx.doi.org/10.21037/tcr-22-1488 Text en 2022 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Wang, Bin
Liu, Bin
Luo, Qing
Sun, Ding
Li, Hao
Zhang, Jie
Jin, Xinye
Cheng, Xiaowei
Niu, Jingxue
Yuan, Qing
Chen, Yizhi
PANK1 associates with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a retrospective prognostic study based on the TCGA database
title PANK1 associates with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a retrospective prognostic study based on the TCGA database
title_full PANK1 associates with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a retrospective prognostic study based on the TCGA database
title_fullStr PANK1 associates with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a retrospective prognostic study based on the TCGA database
title_full_unstemmed PANK1 associates with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a retrospective prognostic study based on the TCGA database
title_short PANK1 associates with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a retrospective prognostic study based on the TCGA database
title_sort pank1 associates with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a retrospective prognostic study based on the tcga database
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372198/
https://www.ncbi.nlm.nih.gov/pubmed/35966310
http://dx.doi.org/10.21037/tcr-22-1488
work_keys_str_mv AT wangbin pank1associateswithcancermetabolismandimmuneinfiltrationinclearcellrenalcellcarcinomaaretrospectiveprognosticstudybasedonthetcgadatabase
AT liubin pank1associateswithcancermetabolismandimmuneinfiltrationinclearcellrenalcellcarcinomaaretrospectiveprognosticstudybasedonthetcgadatabase
AT luoqing pank1associateswithcancermetabolismandimmuneinfiltrationinclearcellrenalcellcarcinomaaretrospectiveprognosticstudybasedonthetcgadatabase
AT sunding pank1associateswithcancermetabolismandimmuneinfiltrationinclearcellrenalcellcarcinomaaretrospectiveprognosticstudybasedonthetcgadatabase
AT lihao pank1associateswithcancermetabolismandimmuneinfiltrationinclearcellrenalcellcarcinomaaretrospectiveprognosticstudybasedonthetcgadatabase
AT zhangjie pank1associateswithcancermetabolismandimmuneinfiltrationinclearcellrenalcellcarcinomaaretrospectiveprognosticstudybasedonthetcgadatabase
AT jinxinye pank1associateswithcancermetabolismandimmuneinfiltrationinclearcellrenalcellcarcinomaaretrospectiveprognosticstudybasedonthetcgadatabase
AT chengxiaowei pank1associateswithcancermetabolismandimmuneinfiltrationinclearcellrenalcellcarcinomaaretrospectiveprognosticstudybasedonthetcgadatabase
AT niujingxue pank1associateswithcancermetabolismandimmuneinfiltrationinclearcellrenalcellcarcinomaaretrospectiveprognosticstudybasedonthetcgadatabase
AT yuanqing pank1associateswithcancermetabolismandimmuneinfiltrationinclearcellrenalcellcarcinomaaretrospectiveprognosticstudybasedonthetcgadatabase
AT chenyizhi pank1associateswithcancermetabolismandimmuneinfiltrationinclearcellrenalcellcarcinomaaretrospectiveprognosticstudybasedonthetcgadatabase